根据最新公告,英派药业-B(股票代码:07630.HK)已确定其全球发售的最终发售价为每股H股20.10港元。此次定价标志着公司上市进程中的关键一步已完成。
根据最新公告,英派药业-B(股票代码:07630.HK)已确定其全球发售的最终发售价为每股H股20.10港元。此次定价标志着公司上市进程中的关键一步已完成。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.